SC IL-1Ra in SAH - Phase III Trial (SCIL)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew King
University of Manchester
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Derriford Hospital
Plymouth, Devon, United Kingdom
- Royal Hallamshire Hospital
Sheffield, South Yorkshire, United Kingdom
- University Hospital of Wales
Cardiff, Wales, United Kingdom
- Leeds General Infirmary
Leeds, Yorkshire, United Kingdom
- Royal Sussex County Hospital
Brighton, United Kingdom
- Southmead Hospital
Bristol, United Kingdom
- Addenbrookes Hospital
Cambridge, United Kingdom
- the Walton Centre
Liverpool, United Kingdom
- Charing Cross Hospital
London, United Kingdom
- National Hospital for Neurology and Neurosurgery, Queen Square
London, United Kingdom
- Royal London Hospital
London, United Kingdom
- St George'S Hospital
London, United Kingdom
- Northern Care Alliance Nhs Foundation Trust
Manchester, United Kingdom
- Queens Medical Centre
Nottingham, United Kingdom
- Royal Preston Hospital
Preston, United Kingdom
- Southampton General Hospital
Southampton, United Kingdom
- Royal Stoke University Hospital
Stoke-on-Trent, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Oct 2018
- Primary completion
- 30 Apr 2024
- Completion
- 30 Sept 2024
- Last update posted
- 21 Nov 2023
- Registered enrollment
- 612
- Registry id
- NCT03249207
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.